Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein

Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...

Full description

Bibliographic Details

Main Authors:	Wright, D., Allen, E.R., Clark, M.H.A., Gitonga, J.N., Karanja, H.K., Hulswit, R.J.G., Taylor, I., Biswas, S., Marshall, J., Mwololo, D., Muriuki, J., Bett, Bernard K., Bowden, T.A., Warimwe, G.M.
Format:	Journal Article
Language:	Inglés
Published:	Elsevier 2020
Subjects:	immunology virology rift valley fever virus
Online Access:	https://hdl.handle.net/10568/109976